The Same But Different: Biden Budget Proposes Flexibility For Generic Drug-Device Combos, ‘Skinny Labels’
Executive Summary
President Biden's fiscal year 2024 budget pushes new legislative changes to get generic drugs to market faster.
You may also be interested in...
Biosimilar Interchangeability Designation Would Be Nixed Under Biden Proposal
The proposal is not expected to cost or save the government money, but is expected to increase biosimilar uptake, according to budget documents.
Biosimilar Interchangeability Designation Would Be Nixed Under Biden Proposal
The proposal is not expected to cost or save the government money, but is expected to increase biosimilar uptake, according to budget documents.
US FDA’s Califf Responds To, And Deflects, Senators’ Mifepristone Questions
The Senate Appropriations Subcommittee hearing was called to discuss the agency’s FY 2024 budget request, but several committee members wanted to talk about the pending Supreme Court decision on the medication abortion drug.